The effect of chronic digitalization on pump function in systolic heart failure

Area of Science:

• Cardiology
• Pharmacology

Background:

• Cardiac glycosides, like digitalis, are known to enhance contractility and improve ejection fraction in the short term for systolic heart failure.
• The long-term effects of digitalis on cardiac function in heart failure patients remain less understood.

Purpose of the Study:

• To investigate whether chronic administration of digitalis impacts left ventricular function and overall performance in patients with systolic heart failure.
• To evaluate the sustained effects of digitalis beyond its acute inotropic benefits.

Main Methods:

• A multi-center, randomized, double-blind, placebo-controlled study was conducted involving 80 patients with mild-to-moderate systolic heart failure (ejection fraction ≤45%).
• Left ventricular systolic function was assessed using nuclear ventriculography for ejection fraction and echocardiography for ventricular volumes.
• Follow-up assessments were performed on surviving patients after a mean of 48.4 months.

Main Results:

• No significant differences in ejection fraction or hemodynamic parameters (arterial pressure, ventricular volumes, heart rate) were observed between the digitalis and placebo groups at baseline or end-of-study.
• Patients receiving digitalis required significantly less diuretic use compared to the placebo group.
• Patients in the digitalis arm who withdrew from the study remained on the drug for a longer duration.

Conclusions:

• Chronic digitalis treatment for mild-to-moderate systolic heart failure did not demonstrate an improvement in left ventricular systolic function or performance when compared to placebo.
• The observed clinical benefits of digitalis in heart failure cannot be attributed to a sustained inotropic effect.
• Digitalis may play a role in managing fluid status, as indicated by reduced diuretic use.